Heron Therapeutics Inc. (HRTX) EPS is poised to hit -0.23 next quarter: How Investors Can Make It Count the Most?

Heron Therapeutics Inc. (NASDAQ: HRTX) flaunted slowness of -3.01% at $1.29, as the Stock market unbolted on May 24, 2023. During the day, the stock rose to $1.33 and sunk to $1.26 before settling in for the price of $1.33 at the close. Taking a more long-term approach, HRTX posted a 52-week range of $1.07-$5.62.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 28.50%. Meanwhile, its Annual Earning per share during the time was 14.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 25.40%. This publicly-traded company’s shares outstanding now amounts to $119.25 million, simultaneously with a float of $118.62 million. The organization now has a market capitalization sitting at $142.60 million. At the time of writing, stock’s 50-day Moving Average stood at $2.1187, while the 200-day Moving Average is $3.0582.

It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 203 employees. For the Profitability, stocks gross margin was +49.04, operating margin was -157.20 and Pretax Margin of -169.05.

Heron Therapeutics Inc. (HRTX) Ownership Facts and Figures

Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Heron Therapeutics Inc. industry. Heron Therapeutics Inc.’s current insider ownership accounts for 0.20%, in contrast to 102.55% institutional ownership.

Heron Therapeutics Inc. (HRTX) Earnings and Revenue Records

Going through the last 3-months fiscal report unveiled on the 3/30/2023, it has been observed that the corporation posted -$0.27 earnings per share (EPS) during the time that was less the consensus figure (set at -$0.2) by -$0.07. This company achieved a net margin of -169.05 while generating a return on equity of -399.43. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.

Heron Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 25.40% and is forecasted to reach -0.51 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 47.50% through the next 5 years, which can be compared against the 14.50% growth it accomplished over the previous five years trading on the market.

Heron Therapeutics Inc. (NASDAQ: HRTX) Trading Performance Indicators

Let’s observe the current performance indicators for Heron Therapeutics Inc. (HRTX). It’s Quick Ratio in the last reported quarter now stands at 1.60. The Stock has managed to achieve an average true range (ATR) of 0.20. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.25.

In the same vein, HRTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.37, a figure that is expected to reach -0.23 in the next quarter, and analysts are predicting that it will be -0.51 at the market close of one year from today.

Technical Analysis of Heron Therapeutics Inc. (HRTX)

Now, what If we examine the latest scores posted by [Heron Therapeutics Inc., HRTX]. During the last 5-days, its volume was better the volume of 2.2 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 21.62% While, its Average True Range was 0.1887.

Raw Stochastic average of Heron Therapeutics Inc. (HRTX) in the period of the previous 100 days is set at 9.40%, which indicates a major fall in contrast to 15.28% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 203.83% that was higher than 123.67% volatility it exhibited in the past 100-days period.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Magnite Inc. (MGNI)’s latest performance is not what we had anticipated

Magnite Inc. (NASDAQ: MGNI) kicked off on September 15, 2023, at the price of $8.24, down -2.07% from the previous trading day. During the...

-53.22% percent quarterly performance for Yext Inc. (YEXT) is not indicative of the underlying story

Yext Inc. (NYSE: YEXT) on September 15, 2023, started off the session at the price of $6.46, plunging -2.32% from the previous trading day....

Skyline Champion Corporation (SKY) is 2.88% away from 50-day simple Moving Average despite all headwinds

September 15, 2023, Skyline Champion Corporation (NYSE: SKY) trading session started at the price of $70.62, that was -2.63% drop from the session before....


Please enter your comment!
Please enter your name here